Figure 5.The survival analysis, differential analysis and GSEA of CCL19. (A) The survival analysis between the expression of CCL19 and the survival of breast cancer patients; patients were divided into two groups, high CCL19 expression group and low CCL19 expression group, compared with the median; (B–F) The associations between the expression of CCL19 with age, stage, and TNM classification of breast cancer patients; p value was displayed in the diagram; (G–J) GSEA for genes in high CCL19 expression group in different gene sets, p<0.05 and FDR<0.05 were considered to be statistically significant.
